Atomic Mutagenesis of the Ribosome: Towards a Molecular Understanding of Translation by Polacek, Norbert
322 CHIMIA 2013, 67, Nr. 5 New Professors iN switzerlaNd
doi:10.2533/chimia.2013.322 Chimia 67 (2013) 322–326 © Schweizerische Chemische Gesellschaft
*Correspondence: Prof. Dr. N. Polacek
University of Bern
Department of Chemistry and Biochemistry
Freiestrasse 3
CH-3012 Bern
Tel.: +41 31 631 4320
E-mail: norbert.polacek@dcb.unibe.ch
Atomic Mutagenesis of the Ribosome:
Towards a Molecular Understanding of
Translation
Norbert Polacek*
Abstract: The multifaceted repertoire of non-protein-coding RNAs (ncRNAs) in organisms of all three domains
of life emphasizes their fundamental role in biology. Research in my lab focuses on revealing the regulatory and
catalytic function of small and large ncRNAs in different model organisms. In particular we are interested in
understanding ncRNA/protein complexes such as the vault complex or the ribosome. The ribosome, the central
enzyme of protein biosynthesis, is a multifunctional ribonucleoprotein particle composed of two unequal subunits
that translates the genome’s message into all proteins needed for life. The crucial role the translation machinery
plays in gene expression is also mirrored by the fact that the ribosome represents the main target for antibiotics.
Decades of genetic, biochemical and recent crystallographic studies revealed the ribosome as an RNA-enzyme
with roots in the ‘RNAworld’. Despite these experimental insights, the catalytic and regulatory mechanisms of the
ribosomal RNA are still not fully understood at the molecular level. To unravel the detailed contributions of rRNA
nucleotides for protein synthesis we have developed and applied an ‘atomic mutagenesis’ approach. This tool
allows the role of specific 23S rRNA functional groups and even individual atoms to be studied during various
stages of the ribosomal elongation cycle with thus far unequalled precision. This experimental approach bridges
the disciplines of biochemistry and organic chemistry and has recently revealed specific functional 23S rRNA
groups involved in peptide bond synthesis, peptidyl-tRNA hydrolysis, GTPase activation, and tRNA translocation.
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The Ribosome – An Ancient
Enzyme Powered by RNA Catalysis
The ribosome is a multifunctional
RNA-protein complex and translates the
genome’s message into all proteins needed
for life. Translation of the genetic informa-
tion represents the final step in gene ex-
pression. The crucial role of protein bio-
synthesis in gene expression is highlighted
by the fact that the ribosome represents the
main target for clinically relevant antibiot-
ics. Therefore the knowledge of its func-
tioning is crucial for our understanding
of antibiotic resistance and for the future
design of new anti-microbial compounds.
The ribosome is the largest known RNA
enzyme and is regarded as one of the most
ancient catalysts in biology. The bacte-
rial ribosome has a molecular weight of
2.6–2.8 MDa with about 2/3 of the mass
comprised of ribosomal RNA (rRNA) and
1/3 of ribosomal proteins (r-proteins). The
ribosome is a highly dynamic particle and
can be regarded as a molecular machine
consisting of two unequally sized subunits.
The large 50S subunit contains two rRNA
molecules (the ~2’900 nucleotide-long
23S rRNA and the 120 residue-long 5S
rRNA) and about 33 different r-proteins.
The small 30S subunit on the other hand
carries a single rRNA strand (the ~1’500
nucleotide-long 16S rRNA) and approxi-
mately 20 r-proteins. All ribosomes have
three distinct tRNA binding sites designat-
ed theA-site (aminoacyl-tRNA or acceptor
site), P-site (peptidyl-tRNA or donor site),
and E-site (tRNA exit site).
The catalytic center of the ribosome is
located on the 50S subunit where the in-
dividual amino acid monomers are chemi-
cally linked via peptide bonds to form
the polypeptide chain. This active site
is referred to as the peptidyl transferase
center (PTC) and it is located in a funnel-
shaped deep cleft on the interface side of
the 50S subunit. Peptide bond synthesis
and peptidyl-tRNA (pept-tRNA) hydroly-
sis are the two central chemical reactions
of protein synthesis that take place in the
PTC (for reviews see refs. [1,2]). Peptide
bond formation involves aminolysis by
the α-amino group of the A-site bound
aminoacyl-tRNA (aa-tRNA) of the ester
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ester bond that connects the fully synthe-
sized peptide chain and the tRNA in the
PTC P-site. This reaction is the second
chemical reaction that is catalyzed in the
PTC during protein synthesis. A universal-
ly conserved GGQ tri-peptide motif, which
is located in a flexible loop of the RF,
reaches into the PTC where it contacts and
repositions conserved 23S rRNA residues,
such as the crucial nucleotide A2602.
[15,16]
These structural changes and interactions
with PTC nucleotides are thought to be
critical for the GGQ motif to adopt its
functional conformation and allows it to
coordinate the hydrolytic water molecule
that finally cleaves the pept-tRNA ester
bond.
[17]
Finally, the recycling phase of
translation frees the ribosome from the
mRNA, the tRNAs and the class I RF. The
latter are removed from the ribosome by
the release factor RF3, which represents
another translational GTPase. Before the
ribosome can re-initiate at another mRNA
molecule it needs to be dissociated into its
subunits. This is established via binding
of the ribosomal recycling factor RRF and
EF-G GTPase activity.
[7]
Nucleotide Analog Interference in
the Ribosome Using the Atomic
Mutagenesis Approach
While the crystal structures and cryo-
EM images of ribosomal complexes pro-
vide a wealth of detailed insights, they do
not reveal definite answers about the mo-
lecular mechanisms of ribosome-triggered
reactions. For example, despite the struc-
tural identification of the inner shell 23S
rRNA nucleotides that line up the cata-
lytic center of the ribosome, the detailed
mechanism how peptide bonds are formed
remains controversial and far from being
understood at the molecular level.
[1,2,18–22]
Mutational studies of PTC nucleotides
turned out to be insufficient to unequivo-
cally disclose the contribution of specific
23S rRNA functional groups to translation
at the atomic level.
[23]
It appears that the
level of chemical engineering that can be
generated via standard mutagenesis is not
adequate since it is limited to only three
possible nucleobase changes that can be
introduced by RNA polymerase.
[24]
To circumvent these limitations and to
be able to fully use the structural informa-
tion provided by crystallographic and cryo-
EM studies, we have established an in vitro
genetics approach allowing the site-direct-
ed manipulation of 23S rRNA residues in
the context of the 50S ribosomal subunit at
the functional group or even single atom
level.
[25,26]
This approach permits chang-
ing the chemical characteristic of a specific
residue within an RNA molecule contain-
ing thousands of nucleotides. The key fea-
bond that carries the nascent peptide at the
terminal ribose C3’ position of pept-tRNA.
Subsequent to the nucleophilic attack of
the α-amino group, a short-lived tetrahe-
dral transition state is formed that breaks
down by donating a proton to the leav-
ing oxygen to yield the reaction products
deacylated tRNA at the P-site and pept-
tRNA (elongated by one amino acid) at
theA-site. From an energetic point of view
formation of a peptide bond is a down-
hill reaction since almost 8 kcal/mol are
‘stored’ in the ester bond of aa-tRNA and
only ~0.5 kcal/mol are needed for amide
bond formation. Nevertheless, the uncata-
lyzed reaction (extrapolated from model
reactions) occurs very slowly in solution
with less than one bond formed per day.
[3]
Thus the ribosome accelerates the rate of
peptide bond formation approximately
10
7
-fold.
[4]
The mechanism by which the
PTC accelerates peptide bond formation
has long been a question of rather intense
discussions over decades (reviewed in
ref. [1]). Before the discovery of the first
RNA enzymes an r-protein-based catalytic
mechanism was proposed even though it
had already been realized that the function
of rRNA inside the ribosome exceeds that
of a mere scaffold for the r-proteins. The
debates whether or not the ribosome is a
ribozyme sustained until the beginning
of the new millennium when high-reso-
lution crystallographic structures ended
these disputes by revealing the inner shell
of the PTC as an all-RNA active site.
[5,6]
Five universally conserved residues of do-
main V of 23S rRNA form the catalytic
crevice. Froman evolutionary point of view
it is remarkable that the ribosome, so to say
the mother of all contemporary protein en-
zymes, is an RNA enzyme. Obviously the
PTC proved itself as a very efficient RNA-
based catalyst and has therefore not been
replaced by proteins during the course of
evolution. The ribosome can thus be re-
garded as molecular relic that outlived the
transition from the ‘RNA world’ to con-
temporary biology.
Making Proteins: The Ribosomal
Elongation Cycle
Protein biosynthesis can be divided
into four different steps: initiation, elonga-
tion, termination and recycling.
[7]
During
the elongation cycle of translation, the
tRNAs have to move along a 100 Å path
through the ribosome in steps of 10–30 Å.
The initiator tRNA (fMet-tRNA
fMet
in bac-
teria) is delivered to the 30S particle as
ternary complex with initiation factor 2
(IF2) and GTP, where it binds to the AUG
mRNA start codon which is displayed in
the 30S P-site with the aid of IF1 and IF3.
Subsequently the 50S subunit joins which
results in triggering of the GTPase activ-
ity of IF2 and subsequent dissociation of
the IFs from the 70S initiation complex.
During the elongation phase of transla-
tion, the next amino acid is delivered to
the A-site in form of the ternary complex
composed of aa-tRNA, elongation factor
Tu (EF-Tu) and GTP. Accuracy of transla-
tion is maintained in the 30S decoding cen-
ter by a sophisticated mechanism relying
on monitoring the shape of the codon-anti-
codon mini-helix as well as the conforma-
tion of the tRNA anticodon stem-loop by
highly conserved 16S rRNA elements.
[8,9]
For correct decoding only exact Watson-
Crick interactions between the mRNA
codon and the tRNA anticodon (primar-
ily monitored at the first two nucleotides
of the codon) are allowed and trigger, by
a so far not fully understood signaling
pathway mechanism, GTP hydrolysis on
EF-Tu. EF-Tu•GDP subsequently dissoci-
ates from the aa-tRNA. The acceptor end
of aa-tRNA subsequently swings into the
50S A-site, a process called accommoda-
tion. Also during this accommodation step
discrimination between correct and incor-
rect aa-tRNAs can be achieved, since it has
been shown that the rate of accommoda-
tion for cognate aa-tRNA is significantly
faster than for near-cognate aa-tRNAs and
thus the latter can even be rejected at this
stage.
[10]
Once the CCA terminal acceptor
end of the aa-tRNA is fully accommodated
in the PTC, peptide bond formation occurs
immediately. While catalyzing 15 to 20
peptide bonds per second
[11,12]
the error rate
remains in the range of 10
–3
to 10
–4
.
[10,13,14]
During the course of peptide bond forma-
tion the peptidyl moiety of P-site located
pept-tRNA is transferred to the aa-tRNA
in the A-site. This results in the elongation
of the growing peptide chain by one amino
acid at the C-terminal end. The nascent
peptide departs the catalytic center via the
so-called peptide exit tunnel, a ~100Å long
and rRNA-rich path that spans the entire
50S subunit and has its end at the solvent
side. In the final step of the elongation cycle
the deacylated tRNA and the pept-tRNA
are translocated from the P- and A-sites to
the E- and P-sites, respectively. This well-
orchestrated tRNA/mRNA movement is
promoted by the action of EF-G and GTP
hydrolysis, which results in the entrance of
a newmRNA codon into the decoding cen-
ter of the small ribosomal subunit A-site.
At the end of the open reading frame an
mRNA stop codon (UAA, UAG, or UGA)
is moved into theA-site. This results in the
establishment of the termination phase of
protein biosynthesis. Stop codons are usu-
ally not recognized by tRNA anticodons
but by specific peptide motifs of class I
release factors (RF1 and RF2 in bacteria).
Binding of a class I RF to the A-site of the
ribosome results in the hydrolysis of the
324 CHIMIA 2013, 67, Nr. 5 New Professors iN switzerlaNd
tional GTPases,
[29,30]
and tRNA transloca-
tion.
[31]
One of the most surprising results
of our recent research was the finding that
a single rRNA backbone group, namely the
ribose 2’-OH of the inner core PTC residue
A2451, rather than any of the universally
conserved nucleobases is crucial for pep-
tide bond synthesis (Fig. 2). Introducing
different modifications at this ribose 2’
position with markedly different hydrogen
donor and acceptor characteristics dem-
onstrated that the 2’-OH group at A2451
donates a proton during the course of amid
bond synthesis.
[28]
The data obtained so
far with this approach has enabled us to
put forward a novel catalytic mechanism
for peptide bond synthesis (Fig. 3) that
embraces also relevant data from other re-
search groups.
[32–37]
Does this mean that the PTC nucleo-
bases are not crucial for ribosome func-
tions? The answer is most likely no, since
typically universal conservation indicates
functional relevance. While it seems that
rRNA backbone groups drive ribosome
catalysis
[15,28]
PTC nucleobases are cru-
cial for tRNA translocation. Employing
the atomic mutagenesis approach we
were able to identify the importance of a
non-Watson-Crick base pair between the
two active site residues A2450-C2063 for
tRNA translocation.
[31]
In addition, we
identified a functional group at an adenos-
ine at position A2660 of the 23S rRNA to
be pivotal for activating the GTPase activ-
ity of EF-G (Fig. 2).
[29,30]
A2660 resides
in the so-called sarcin-ricin loop (SRL)
which has been shown previously by bio-
chemical and structural studies (reviewed
in ref. [30]) to be in immediate proximity
to the GTP bound in the active site of trans-
lational GTPases such as EF-G or EF-Tu.
Our atomic mutagenesis studies highlight-
ed the C6 exocyclic amino group at A2660
as a potential trigger of EF-G GTPase ac-
tivity (Fig. 2). Since the chemical nature of
this C6 exocyclic group does not seem to
play a critical role (Fig. 2), we interpreted
our data such that this nucleobase ‘com-
municates’ with the G-domain of the elon-
gation factor via π-stacking interactions of
this adenine with amino acid residues of
EF-G.Alternatively, the exocyclic N6 ami-
no group could be necessary to sterically
clash into EF-G residues at the G domain.
These interactions may act as the trigger to
induce conformational changes within the
G domain of EF-G leading to GTPase ac-
tivation. Due to the universal conservation
of the SRL and the G-domains of transla-
tional GTPases, this might be a commonly
used GTPase activation mechanism among
all translational GTPases, such as initia-
tion factor 2 (IF2), EF-Tu, EF4 (LepA)
or release factor 3. Indeed all of these
translational GTPases have been shown
to equally depend on the presence of this
ture of this approach is the use of circularly
permuted (cp) 23S rRNA transcripts as the
major component for in vitro reconstitution
of 50S particles (see Fig. 1 for details). The
generation of a cp-23S rRNA is possible
without dramatic structural consequences
due to the proximity of the natural 5’ and
3’ ends, which form helix 1 (H1) of native
23S rRNA (Fig 1). The new ends of the
cp-23S rRNA are placed such that a short
sequence gap is introduced (typically be-
tween 25 and 55 nucleotides), which en-
compasses the 23S rRNA residue under
investigation. The missing rRNA segment
is chemically synthesized to either contain
the wild type sequence, or non-natural
nucleoside analogs. During an in vitro
reconstitution procedure this synthetic
RNA piece is assembled with all the other
components of the 50S subunit to form a
large ribosomal subunit. Depending on the
studied ribosomal function, the chemically
engineered 50S subunit can subsequently
be joined with native 30S subunits to yield
a complete 70S ribosome for functional
analyses. Thus with this experimental de-
sign, which we dubbed ‘atomic mutagen-
esis’, individual functional groups or even
single atoms on 23S rRNA residues can be
exchanged within the context of the whole
70S ribosome.
The atomic mutagenesis technique has
so far been successfully applied to study
peptide bond formation,
[26–28]
release fac-
tor-mediated peptidyl-tRNA hydrolysis,
[15]
ribosome-triggered activation of transla-
3’
5’
synthetic
RNA oligo
circularly permuted
23S rRNA
PCR & transcription
in vitro
reconstitution
chemically engineered
50S ribosomal subunit
5S rRNA,
r-proteins
23S rDNA
23S rDNA
T7
H1
Fig. 1. Experimental design of the ‘atomic mutagenesis’ approach. The
circularly permuted (cp) 23S rRNA (schematic secondary structure is
shown in the center) is produced by T7 RNA polymerase in vitro tran-
scription from the cp-23S rDNA template. The cp-23S rDNA is gener-
ated by PCR (PCR primers are depicted as arrows; the forward primer
introduces the T7 RNA polymerase promoter) using a plasmid carrying
tandemly repeated 23S rRNA genes from T. aquaticus. The cp-23S rRNA
is designed so that the natural ends of 23S rRNA, which form helix 1 (H1)
in the native 50S subunit, are covalently connected (bold black line) and
new 5’ and 3’ ends have been introduced. Thereby a short sequence gap
is generated encompassing the residue under investigation. The com-
pensating synthetic RNA oligo (grey) that carries the desired non-natural
nucleoside (asterisk) is used in combination with the remaining compo-
nents of the 50S subunit (5S rRNA and the total r-proteins of the large
subunit of T. aquaticus) to generate chemically engineered 50S subunits
by in vitro reconstitution.
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C6 exocyclic group atA2660.
[30]
Structural
data suggest an alternate or additional ri-
bosomal trigger to fire GTPase activity on
ribosome-bound elongation factors, name-
ly a non-bridging oxygen at the phosphor-
diester bond between SRL residues G2661
and A2662.
[38]
Equipped with the atomic
mutagenesis approach this model can now
be tested experimentally since it enables us
to individually manipulate the suspected
rRNA backbone groups in that region of
the SRL.
Research Directions and
Perspectives
Initial proof of principle experiments
demonstrated that unprecedented molecu-
lar insight can be gained by applying the
atomic mutagenesis approach. However in
these initial applications of the technique
the chemically engineered ribosomes
were used in simplified model reactions
of protein synthesis primarily under single
turnover reaction conditions (e.g. peptide
bond formation, pept-tRNA hydrolysis).
However, protein biosynthesis by the ribo-
some is a very dynamic multi-functional
and iterative process, thus it is possible
that functionally crucial 23S rRNA groups
have been overlooked in these initial stud-
ies. In order to improve the biological
relevance of the assays and to challenge
chemically engineered ribosomes in a
more physiologically relevant system, we
have recently optimized reaction condi-
tions to employ these in vitro generated
particles in genuine in vitro translation
reactions. And indeed chemically engi-
neered ribosomes turned out to be active in
poly(U)-directed poly(Phe) synthesis and,
more importantly, also in translation reac-
tions using natural mRNA templates (Fig
4).
[25]
Currently we use the atomic muta-
genesis approach to (i) study the function
of the 50S E-site, (ii) to ‘retro-evolve’ a
miniaturized functional ribosome, and
(iii) to learn more about the regulatory po-
tential of interactions between the grow-
ing peptide chain, as it leaves the PTC, and
the nascent peptide exit tunnel wall in the
large ribosomal subunit.
The experimental evidence gathered
to date with the atomic mutagenesis tech-
nique open doors for novel avenues of
biochemical research and revealed the ri-
bosome, the largest known ribozyme, as
being amenable to synthetic biology ap-
proaches.
[23]
It appears possible that the
chemical characteristic of the ribosome
can be rationally engineered utilizing the
‘atomic mutagenesis’ approach to gener-
ate an in vitro translation system that al-
lows the synthesis of ‘designer peptides’
carrying, for example, several consecutive
unnatural amino acids.
3’
3’
5’
5’
2451
2660
EF-G GTPase activity
peptide bond formation
PTC
SRL
A (wt)
A (wt) dA
dA
c A
r-aba
r-aba
d-aba
3
A
U
U
C
2’-NH -A2,6-DAP
2’-F-A
2
Pu
m A
6
2
m Pu
6
I
C
H
NH
CHH C
NH
2
33
2
NH
2
2
F
H
H
H
O
1.00
1.00 0.70 0.12
1.06 1.25 0.81
0.11
0.03
0.930.70
0.77
0.53
< 0.01
< 0.06
Fig. 2. Atomic mutagenesis at A2451 in the peptidyl transferase center (PTC) and at A2660 in
the sarcin-ricin-loop (SRL) of 23S rRNA. Secondary structures of the respective active sites are
shown whereas the newly introduced endpoints of the cp-23S rRNA constructs are shown (5’ and
3’, respectively). The chemically synthesized RNA oligos, which compensate for the missing rRNA
fragments, are shown in grey and are held in place by Watson-Crick base pairing with the cp-23S
rRNAs. The chemical structures of nucleoside analogs that were introduced at A2451 or A2660
are depicted and the relative rates of peptide bond formation
[26,28]
or EF-G GTPase activity
[29]
are
shown for each nucleoside analog above the structures. The rates were normalized to reconsti-
tuted ribosomes containing the synthetic wild-type RNA fragment. Tested nucleoside analogs:
dA: 2’-deoxy-adenosine; c
3
A: 3-deaza-adenosine; 2’-F-A: 2’-fluoro-adenosine; 2,6-DAP: 2,6-di-
aminopurine; 2’-NH
2
-A: 2’-amino-adenosine; d-aba: 2’-deoxy-ribose-abasic analog; r-aba: ribose-
abasic analog; Pu: purine; m
6
2
A: N6,N6-dimethyladenosine; I: inosine; m
6
Pu: 6-methylpurine.
P-site
peptidyl-tRNA
A-site
aminoacyl-tRNA
23S rRNA
A2451
R
Fig. 3. Model for the mechanism of peptide bond formation proposing a role for A2451 based on
our experimental finding that its hydrogen donor propensity is a stringent requirement for activity.
[28]
The A2451 2’-O-H ··· O(2’) A76 hydrogen bond assists in P-site tRNA A76 ribose positioning in
its functionally competent confirmation and in suppression of spontaneous intra-molecular trans-
esterification. In this model the nucleophilic attack of the α-amino group of A-site bound amino-
acyl-tRNA on the ester carbonyl carbon is accompanied by a concomitant acceptance of a proton
from the α-amino group by the A76 2’-O of the peptidyl-tRNA which simultaneously donates its
proton to the vicinal 3’-O. Arrows indicate pair-wise electron movement for proton shuttling after
the attack of the α-amino nucleophile has established the tetrahedral intermediate.
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Fig. 4. Chemically engineered ribosomes are
active in in vitro translation. In vitro assembled
ribosomes, programmed with mRNAs encod-
ing either r-protein S8 or the enzyme chlor-
amphenicol acetyltransferase, are capable of
translating full-length [
35
S]-labeled proteins
(arrow heads). The reaction products were
separated via SDS polyacrylamide gel electro-
phoresis. Results with three different cp-23S
rRNA constructs are shown that allow distinct
50S active sites to be investigated by the
atomic mutagenesis approach (PTC: peptidyl
transferase center; ex. tunnel: nascent peptide
exit tunnel; SRL: sarcin-ricin-loop). Also in this
assay the requirement for a ribose 2’-OH group
at A2451 is evident (top gel). Lanes labeled
with ‘M’ show an aliquot of an in vitro transla-
tion reaction using native 70S ribosomes from
E. coli and serve as length markers. For abbre-
viation of nucleoside analogs see Fig. 2.
